4
Changes in Ownership
VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-25-000236
EVP, Chief Technical Ops. Off. sold 2,500 shares at $434.58 ($1,086,450)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Atkinson Edward Morrow III · EVP, Chief Technical Ops. Off.
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-11-17 | Sale : show line 1 in the form 10b5-1 | −2,500 | $434.58 | $1,086,450 | 16,852 | D |
| Open-market sales · 2,500 sh · avg $434.58 · $1,086,450 | ||||||
Loading xslF345X05/wk-form4_1763586372.xml…